Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan G Duda

Showing results (131-140 of 261) with videos related to

Pageof 27
Sort By:
Biorxiv : the Preprint Server for Biology|March 17, 2025
Inhibiting B-cell-mediated Immunosuppression to Enhance the Immunotherapy Efficacy in Hepatocellular CarcinomaXin Liu, Zelong Liu, Tatsuya Kobayashi, et al.
Nature Communications|February 10, 2022
Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapyYuling Xiao, Jiang Chen, Hui Zhou, et al.
Clinical Ovarian Cancer and Other Gynecologic Malignancies|August 12, 2011
Safety, Efficacy, and Biomarker Exploration in a Phase II Study of Bevacizumab, Oxaliplatin, and Gemcitabine in Recurrent Müllerian CarcinomaNeil S Horowitz, Richard T Penson, Dan G Duda, et al.
United European Gastroenterology Journal|November 23, 2017
Use of inhibitors of the renin-angiotensin system is associated with longer survival in patients with hepatocellular carcinomaMatthias Pinter, Arndt Weinmann, Marcus-Alexander Wörns, et al.
Pancreas|April 16, 2004
The role of chromosome 18 abnormalities in the progression of pancreatic adenocarcinomaMakoto Sunamura, Liviu P Lefter, Dan G Duda, et al.
Research Square|May 5, 2025
Inhibiting B-cell-mediated Immunosuppression to Enhance the Immunotherapy Efficacy in Hepatocellular CarcinomaXin Liu, Zelong Liu, Tatsuya Kobayashi, et al.
Cancers|May 24, 2020
Potential Circulating Biomarkers of Recurrence after Hepatic Resection or Liver Transplantation in Hepatocellular Carcinoma PatientsDan G Duda, Simona O Dima, Dana Cucu, et al.
International Journal of Radiation Oncology, Biology, Physics|February 5, 2023
Predictive Model of Liver Toxicity to Aid the Personalized Selection of Proton Versus Photon Therapy in Hepatocellular CarcinomaIbrahim Chamseddine, Yejin Kim, Brian De, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 22, 2025
Targeting EPHB2/ABL1 restores antitumor immunity in preclinical models of ependymomaJun Ren, Zohreh Amoozgar, Taylor P Uccello, et al.
Radiation Oncology (London, England)|March 5, 2021
Combining losartan with radiotherapy increases tumor control and inhibits lung metastases from a HER2/neu-positive orthotopic breast cancer modelWende Li, Sen Li, Ivy X Chen, et al.
Pageof 27

Showing results (131-140 of 261) with videos related to

Sort By:
Pageof 27
Biorxiv : the Preprint Server for Biology|March 17, 2025
Inhibiting B-cell-mediated Immunosuppression to Enhance the Immunotherapy Efficacy in Hepatocellular CarcinomaXin Liu, Zelong Liu, Tatsuya Kobayashi, et al.
Nature Communications|February 10, 2022
Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapyYuling Xiao, Jiang Chen, Hui Zhou, et al.
Clinical Ovarian Cancer and Other Gynecologic Malignancies|August 12, 2011
Safety, Efficacy, and Biomarker Exploration in a Phase II Study of Bevacizumab, Oxaliplatin, and Gemcitabine in Recurrent Müllerian CarcinomaNeil S Horowitz, Richard T Penson, Dan G Duda, et al.
United European Gastroenterology Journal|November 23, 2017
Use of inhibitors of the renin-angiotensin system is associated with longer survival in patients with hepatocellular carcinomaMatthias Pinter, Arndt Weinmann, Marcus-Alexander Wörns, et al.
Pancreas|April 16, 2004
The role of chromosome 18 abnormalities in the progression of pancreatic adenocarcinomaMakoto Sunamura, Liviu P Lefter, Dan G Duda, et al.
Research Square|May 5, 2025
Inhibiting B-cell-mediated Immunosuppression to Enhance the Immunotherapy Efficacy in Hepatocellular CarcinomaXin Liu, Zelong Liu, Tatsuya Kobayashi, et al.
Cancers|May 24, 2020
Potential Circulating Biomarkers of Recurrence after Hepatic Resection or Liver Transplantation in Hepatocellular Carcinoma PatientsDan G Duda, Simona O Dima, Dana Cucu, et al.
International Journal of Radiation Oncology, Biology, Physics|February 5, 2023
Predictive Model of Liver Toxicity to Aid the Personalized Selection of Proton Versus Photon Therapy in Hepatocellular CarcinomaIbrahim Chamseddine, Yejin Kim, Brian De, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 22, 2025
Targeting EPHB2/ABL1 restores antitumor immunity in preclinical models of ependymomaJun Ren, Zohreh Amoozgar, Taylor P Uccello, et al.
Radiation Oncology (London, England)|March 5, 2021
Combining losartan with radiotherapy increases tumor control and inhibits lung metastases from a HER2/neu-positive orthotopic breast cancer modelWende Li, Sen Li, Ivy X Chen, et al.
Pageof 27